The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Leaders Converge on Capitol Hill

ACR Leaders Converge on Capitol Hill

February 1, 2013 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR volunteer leaders will be on Capitol Hill this month meeting face to face with key decision makers and discussing legislative and regulatory issues that affect the rheumatology community. The ACR Advocacy Leadership Conference takes place every spring in Washington, D.C. The conference is attended by members of the ACR Government Affairs Committee, RheumPAC Committee, and the Affiliate Society Council. In-person meetings with members of Congress are a critical piece of ACR’s advocacy program. These meetings support our efforts to influence national healthcare policy and ensure that policy makers are educated on the importance of the rheumatology subspecialty.

You Might Also Like
  • ACR Leaders to Converge on Capitol Hill
  • Participate in Virtual Capitol Hill Meetings with the ACR
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
Explore This Issue
February 2013
Also By This Author
  • Rheum With a View

During the 2013 Advocacy Leadership Conference, the ACR is focused on educating recently elected members of Congress on our legislative priorities, including physician payment reform, patient access to treatment, and funding for medical research. While Congress passed a one-year fix to temporarily avert physician payment cuts at the end of 2012, the ACR is urging Congress to permanently replace the flawed SGR system that leads to this deepening annual crisis. The new model must recognize through appropriate reimbursement the specialized care rheumatologists provide.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ACR advocates are also urging members of Congress to co-sponsor the Patients’ Access to Treatment Act of 2013. This bipartisan legislation, introduced by Representatives David McKinley (R-WV) and Lois Capps (D-CA), would place specialty-tier drugs, including biologics used to treat arthritis and other rheumatic diseases, within the confines of Tier III nonpreferred drugs. This move would mean that commercial health insurers would impose the same co-payment obligations for specialty drugs as they already do for Tier III medications. This critical legislation will help more patients to adhere to necessary treatment regimens by reducing the cost-sharing barriers to treatment.

Calling All Advocates—Meet with your Elected Officials at Home!

Meeting with members of Congress in Washington, D.C. is an important and effective way to convey the ACR’s legislative priorities to elected officials. However, you don’t have to travel to Washington to get involved. Members of Congress have regularly scheduled district work periods when they take time to meet with constituents in their local district offices. The ACR encourages you to schedule a district meeting to help educate your legislators and ensure the viability of the rheumatology subspecialty. For information on district work period schedules or assistance setting up a meeting, please contact [email protected] or call (404) 633-3777 to speak with ACR government affairs staff. ACR staff can handle the logistics of the meeting for you, so you can focus on your message to your representative. Your engagement is critically important and appreciated.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College, Legislation & Advocacy Tagged With: AC&R, Advocacy, Legislation, regulatoryIssue: February 2013

You Might Also Like:
  • ACR Leaders to Converge on Capitol Hill
  • Participate in Virtual Capitol Hill Meetings with the ACR
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
  • ACR Board of Directors Advocates for Rheumatology on Capitol Hill

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)